
Vivodyne is a biotechnology company revolutionizing therapeutics development by providing preclinical human data before clinical trials. Their platform integrates three key breakthroughs: complex human tissue engineering using lab-grown organ models, highly scalable robotics for massive automated studies testing thousands of human tissues simultaneously, and cutting-edge AI for data analysis and experimental design. This enables them to generate predictive human data at AI-scale, accelerating the discovery of new targets and therapies. Vivodyne partners with leading biopharma companies, claiming to have collaborated with over half of the top-10 pharmaceutical companies worldwide, to bring safer and more effective treatments to patients, aiming to replace animal testing with a more sustainable, human-relevant solution.

Vivodyne is a biotechnology company revolutionizing therapeutics development by providing preclinical human data before clinical trials. Their platform integrates three key breakthroughs: complex human tissue engineering using lab-grown organ models, highly scalable robotics for massive automated studies testing thousands of human tissues simultaneously, and cutting-edge AI for data analysis and experimental design. This enables them to generate predictive human data at AI-scale, accelerating the discovery of new targets and therapies. Vivodyne partners with leading biopharma companies, claiming to have collaborated with over half of the top-10 pharmaceutical companies worldwide, to bring safer and more effective treatments to patients, aiming to replace animal testing with a more sustainable, human-relevant solution.